|Bid||22.82 x 1000|
|Ask||22.86 x 800|
|Day's range||20.80 - 23.42|
|52-week range||2.43 - 67.00|
|Beta (5Y monthly)||2.86|
|PE ratio (TTM)||N/A|
|Earnings date||17 Feb 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||19.32|
Canadian weed giant Tilray (NASDAQ: TLRY) was on a tear for much of 2020. Investors have a lot to be thrilled about with Tilray, the most promising of which is its substantial international presence, which will become a game-changer as more countries legalize the recreational and medical use of cannabis. Let's investigate how Tilray can capitalize on marijuana's entry to the mainstream.
The Canadian pot stock rose amid a Reddit-fueled rally and positive earnings results from Tilray, which will merge with Aphria next quarter.
Tilray (NASDAQ: TLRY) stock outperformed a rising market last month. Shares soared 35% in February compared to a 2.6% gain in the S&P 500, according to data provided by S&P Global Market Intelligence. Tilray announced positive earnings results last month, with fourth-quarter sales increasing 26% as net loss improved to $3 million from $220 million a year earlier.